Snyder Mark Howard sold HALO
February 16, 2026 · Form 4 insider transaction
Snyder Mark Howard sold 6,481 shares of Halozyme Therapeutics, Inc. at $79.44 per share, a transaction worth $514.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
6,481
Price
$79.44
Total value
$514.9K
InsiderSnyder Mark Howard
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 16, 2026
Filing dateFebruary 17, 2026
Shares owned after41,925
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported disposition of 6,481 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.